|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.27 USD | -0.60% |
|
-4.04% | +3.54% |
| 06-30 | June Domestic Box Office Likely to Set Up Best Second-Quarter Post COVID-19, B. Riley Says | MT |
| 06-28 | IMAX Corporation(NYSE:IMAX) added to Russell 2000 Defensive Index | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.35 | -0.03 | 4.11 | 3.85 | 6.82 | |||||
Return on Total Capital | 0.46 | -0.03 | 5.52 | 4.99 | 8.56 | |||||
Return On Equity % | -2.14 | -5.23 | 9.79 | 9.04 | 11.3 | |||||
Return on Common Equity | -5.95 | -7.36 | 9.44 | 9.1 | 10.94 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 52.52 | 52.27 | 57.38 | 54.97 | 60.17 | |||||
SG&A Margin | 47.35 | 46.18 | 38.63 | 37.79 | 33.81 | |||||
EBITDA Margin % | 16.59 | 12.2 | 24.25 | 25.33 | 33.04 | |||||
EBITA Margin % | 4.47 | 1.91 | 15.95 | 16.35 | 25.09 | |||||
EBIT Margin % | 2.09 | -0.12 | 14.36 | 14.37 | 22.94 | |||||
Income From Continuing Operations Margin % | -3.76 | -6.61 | 8.82 | 9.28 | 11.1 | |||||
Net Income Margin % | -8.76 | -7.58 | 6.76 | 7.4 | 8.5 | |||||
Net Avail. For Common Margin % | -8.76 | -7.58 | 6.76 | 7.4 | 8.5 | |||||
Normalized Net Income Margin | -4.89 | -1.97 | 6.19 | 6.05 | 11.04 | |||||
Levered Free Cash Flow Margin | 15.54 | 10.85 | 14.09 | 19.56 | 22.22 | |||||
Unlevered Free Cash Flow Margin | 16.29 | 11.02 | 14.63 | 20.43 | 22.86 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.27 | 0.35 | 0.46 | 0.43 | 0.48 | |||||
Fixed Assets Turnover | 0.95 | 1.17 | 1.51 | 1.46 | 1.7 | |||||
Receivables Turnover (Average Receivables) | 1.35 | 1.29 | 1.46 | 1.34 | 1.56 | |||||
Inventory Turnover (Average Inventory) | 3.64 | 4.91 | 5.06 | 4.92 | 5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.13 | 3.22 | 3.29 | 3.92 | 4.35 | |||||
Quick Ratio | 3.77 | 2.87 | 2.92 | 3.49 | 3.92 | |||||
Operating Cash Flow to Current Liabilities | 0.05 | 0.14 | 0.48 | 0.67 | 1.14 | |||||
Days Sales Outstanding (Average Receivables) | 271.37 | 282.59 | 250.75 | 273.5 | 234.05 | |||||
Days Outstanding Inventory (Average Inventory) | 100.29 | 74.31 | 72.11 | 74.33 | 72.99 | |||||
Average Days Payable Outstanding | 61.95 | 50.72 | 58.96 | 52.87 | 43.96 | |||||
Cash Conversion Cycle (Average Days) | 309.72 | 306.18 | 263.9 | 294.95 | 263.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 55.95 | 84.51 | 76.76 | 73.53 | 67.72 | |||||
Total Debt / Total Capital | 35.88 | 45.8 | 43.43 | 42.37 | 40.38 | |||||
LT Debt/Equity | 55.17 | 84.2 | 75.82 | 72.78 | 66.95 | |||||
Long-Term Debt / Total Capital | 35.38 | 45.64 | 42.89 | 41.94 | 39.91 | |||||
Total Liabilities / Total Assets | 51.27 | 59.84 | 57.58 | 54.45 | 52.16 | |||||
EBIT / Interest Expense | 0.75 | -0.06 | 7.89 | 6.26 | 12.78 | |||||
EBITDA / Interest Expense | 6.06 | 6.35 | 13.4 | 11.07 | 18.47 | |||||
(EBITDA - Capex) / Interest Expense | 4.13 | 1.55 | 9.81 | 7.02 | 13.5 | |||||
Total Debt / EBITDA | 5.6 | 7.47 | 2.9 | 3.11 | 2.13 | |||||
Net Debt / EBITDA | 1.19 | 4.86 | 2.07 | 1.98 | 1.02 | |||||
Total Debt / (EBITDA - Capex) | 8.21 | 30.66 | 3.96 | 4.9 | 2.92 | |||||
Net Debt / (EBITDA - Capex) | 1.74 | 19.95 | 2.83 | 3.13 | 1.39 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 86.04 | 18.02 | 24.61 | -6.04 | 16.47 | |||||
Gross Profit, 1 Yr. Growth % | 499.67 | 17.45 | 36.81 | -10 | 27.49 | |||||
EBITDA, 1 Yr. Growth % | -151.74 | -13.22 | 147.68 | -5.27 | 51.9 | |||||
EBITA, 1 Yr. Growth % | -109.83 | -49.48 | 938.66 | -8.71 | 78.68 | |||||
EBIT, 1 Yr. Growth % | -104.34 | -106.53 | -15.61K | -11.4 | 85.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -93.92 | 107.55 | -266.35 | -1.1 | 39.21 | |||||
Net Income, 1 Yr. Growth % | -84.47 | 2.11 | -211.12 | 2.86 | 33.83 | |||||
Normalized Net Income, 1 Yr. Growth % | -81.35 | -52.55 | -491.95 | -15.68 | 112.66 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -84.36 | 5.87 | -214.34 | 4.35 | 31.25 | |||||
Accounts Receivable, 1 Yr. Growth % | 40.08 | 13.74 | 8.84 | -4.74 | 4.63 | |||||
Inventory, 1 Yr. Growth % | -31.98 | 17.12 | 0.16 | 3.98 | -1.02 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.14 | -2.86 | -3.79 | -1.3 | 1.16 | |||||
Total Assets, 1 Yr. Growth % | -11.48 | -7.03 | -0.79 | 1.93 | 7.66 | |||||
Tangible Book Value, 1 Yr. Growth % | -10.57 | -39.52 | 4.22 | 14.15 | 22.77 | |||||
Common Equity, 1 Yr. Growth % | -9.62 | -26.04 | 3.72 | 9.64 | 12.83 | |||||
Cash From Operations, 1 Yr. Growth % | -126.36 | 185.59 | 238.4 | 20.85 | 79.38 | |||||
Capital Expenditures, 1 Yr. Growth % | 86.15 | 106.28 | -13.24 | 33.8 | 11.67 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 108.96 | -17.58 | 61.77 | 25.51 | 32.33 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 85.11 | -20.19 | 65.47 | 26.46 | 30.29 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -19.74 | 48.18 | 21.27 | 8.21 | 4.61 | |||||
Gross Profit, 2 Yr. CAGR % | -21.34 | 165.39 | 26.76 | 10.93 | 7.12 | |||||
EBITDA, 2 Yr. CAGR % | -40.89 | -32.99 | 46.61 | 55.09 | 22.11 | |||||
EBITA, 2 Yr. CAGR % | -63.58 | -77.72 | 129.06 | 205.86 | 31.2 | |||||
EBIT, 2 Yr. CAGR % | -74.16 | -94.68 | 218.25 | 2.99K | 32.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -59.56 | -64.47 | 85.81 | 28.27 | 17.34 | |||||
Net Income, 2 Yr. CAGR % | -30.98 | -60.18 | 6.52 | 6.91 | 17.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | -42.41 | -70.25 | 36.38 | 93.83 | 39.73 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -29.29 | -59.31 | 10.02 | 9.23 | 17.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.65 | 26.22 | 11.26 | 1.83 | -0.17 | |||||
Inventory, 2 Yr. CAGR % | -20.86 | -10.74 | 8.31 | 2.05 | 1.45 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.89 | -4.52 | -3.33 | -2.56 | -0.08 | |||||
Total Assets, 2 Yr. CAGR % | -0.33 | -9.28 | -3.96 | 0.56 | 4.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | -21.6 | -26.46 | -20.61 | 9.07 | 18.38 | |||||
Common Equity, 2 Yr. CAGR % | -19.37 | -18.24 | -12.42 | 6.64 | 11.22 | |||||
Cash From Operations, 2 Yr. CAGR % | -74.09 | -13.24 | 210.88 | 102.23 | 47.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | -46.56 | 95.96 | 33.78 | 7.75 | 22.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -20.77 | 31.24 | 15.47 | 44.7 | 31.37 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -19.66 | 21.55 | 14.92 | 46.8 | 30.75 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -12.03 | -8.73 | 39.86 | 11.38 | 10.89 | |||||
Gross Profit, 3 Yr. CAGR % | -13.73 | -10.1 | 112.79 | 13.08 | 16.2 | |||||
EBITDA, 3 Yr. CAGR % | -27.33 | -32.82 | 3.61 | 28.26 | 54.02 | |||||
EBITA, 3 Yr. CAGR % | -46.65 | -59.38 | -19.8 | 71.62 | 155.69 | |||||
EBIT, 3 Yr. CAGR % | -57.56 | -83.66 | -23.97 | 111.97 | 1.11K | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -34.19 | -30.25 | -40.56 | 50.58 | 31.82 | |||||
Net Income, 3 Yr. CAGR % | -0.76 | -21.35 | -43.94 | 5.28 | 15.22 | |||||
Normalized Net Income, 3 Yr. CAGR % | -26.75 | -46.01 | -29.73 | 19.53 | 99.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.82 | -19.11 | -42.58 | 8.1 | 16.13 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.53 | 9.64 | 20.14 | 5.65 | 2.75 | |||||
Inventory, 3 Yr. CAGR % | -15.46 | -9.81 | -7.25 | 6.85 | 1.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.47 | -6.24 | -4.28 | -2.66 | -1.33 | |||||
Total Assets, 3 Yr. CAGR % | 0.37 | -2.61 | -6.53 | -2.04 | 2.87 | |||||
Tangible Book Value, 3 Yr. CAGR % | -12.51 | -28.1 | -17.39 | -10.39 | 13.46 | |||||
Common Equity, 3 Yr. CAGR % | -11.41 | -21.66 | -11.5 | -5.61 | 8.66 | |||||
Cash From Operations, 3 Yr. CAGR % | -61.94 | -42.34 | 36.57 | 126.89 | 94.31 | |||||
Capital Expenditures, 3 Yr. CAGR % | -34.27 | -16.17 | 49.36 | 33.79 | 9.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -7.64 | -19.72 | 40.72 | 20.25 | 40.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -6.61 | -19.84 | 34.71 | 20.11 | 41.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -7.48 | -4.61 | 0.02 | -2.3 | 24.52 | |||||
Gross Profit, 5 Yr. CAGR % | -7.9 | -3.23 | 0.62 | -2.2 | 61.7 | |||||
EBITDA, 5 Yr. CAGR % | -13.79 | -15.17 | -3.78 | -5.91 | 10.65 | |||||
EBITA, 5 Yr. CAGR % | -28.83 | -35.77 | -4.45 | -7.68 | -2.35 | |||||
EBIT, 5 Yr. CAGR % | -38.25 | -62.74 | -4.99 | -8.65 | -5.14 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -24.61 | 9.69 | -0.32 | -11 | -21.98 | |||||
Net Income, 5 Yr. CAGR % | -4.95 | 57.61 | 2.09 | -11.08 | -24.67 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.85 | -20.82 | -6.07 | -10.75 | -7.5 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.98 | 62.18 | 5.02 | -8.78 | -23.66 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.87 | 8.09 | 9.62 | 6.44 | 11.57 | |||||
Inventory, 5 Yr. CAGR % | -8.56 | 0.48 | -6.65 | -5.24 | -3.86 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.19 | -1.79 | -2.82 | -4.78 | -2.62 | |||||
Total Assets, 5 Yr. CAGR % | 0.6 | -1.07 | -1.39 | -1.36 | -2.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | -9.81 | -17.22 | -15.85 | -15.06 | -4.61 | |||||
Common Equity, 5 Yr. CAGR % | -8.72 | -12.98 | -11.81 | -11.37 | -3.03 | |||||
Cash From Operations, 5 Yr. CAGR % | -39.98 | -27.31 | -11.82 | -4.76 | 40.74 | |||||
Capital Expenditures, 5 Yr. CAGR % | -25.14 | -15.82 | -12.66 | -7.32 | 37.85 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.47 | -4.8 | 0.99 | 1.77 | 36.9 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.1 | -4.81 | 1.47 | 2.26 | 33.11 |
- Stock Market
- Stocks
- IMAX Stock
- Financials IMAX Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















